Nasus Pharma (NSRX) Operating Margin
Nasus Pharma (NSRX) operating margin history. The current Nasus Pharma (NSRX) operating margin is -0.40%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Annual Operating Margin change of Nasus Pharma (NSRX)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -0.40% | N/A |
Comparison Nasus Pharma (NSRX) operating margin with competitors
Nasus Pharma (NSRX) operating margin is -0.40%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 61.57% | -15618.15% |
| GILD | Gilead Sciences Inc | 37.16% | -9465.84% |
| NVS | Novartis AG | 31.31% | -7991.40% |
| AMGN | AMGEN Inc | 30.94% | -7898.14% |
| GSK | GSK Plc | 30.06% | -7676.35% |
| AZN | Astrazeneca plc | 27.77% | -7099.17% |
| ABBV | Abbvie Inc | 26.60% | -6804.29% |
| JNJ | Johnson & Johnson | 26.58% | -6799.24% |
| SNY | Sanofi | 20.18% | -5186.18% |
| OGN | Organon & Company | 18.22% | -4692.18% |
| GRFS | Grifols SA | 14.65% | -3792.40% |